Distinct Expression/Function of Potassium and Chloride Channels Contributes to the Diverse Volume Regulation in Cortical Astrocytes of GFAP/EGFP Mice by Benesova, Jana et al.
Distinct Expression/Function of Potassium and Chloride
Channels Contributes to the Diverse Volume Regulation
in Cortical Astrocytes of GFAP/EGFP Mice
Jana Benesova
1,3, Vendula Rusnakova
2, Pavel Honsa
1,3, Helena Pivonkova
1,3, David Dzamba
1,3, Mikael
Kubista
2,4, Miroslava Anderova
1*
1Department of Cellular Neurophysiology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, 2Laboratory of Gene
Expression, Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic, 3Second Medical Faculty, Charles University, Prague, Czech
Republic, 4TATAA Biocenter, Gothenburg, Sweden
Abstract
Recently, we have identified two astrocytic subpopulations in the cortex of GFAP-EGFP mice, in which the astrocytes are
visualized by the enhanced green–fluorescent protein (EGFP) under the control of the human glial fibrillary acidic protein
(GFAP) promotor. These astrocytic subpopulations, termed high response- (HR-) and low response- (LR-) astrocytes, differed
in the extent of their swelling during oxygen-glucose deprivation (OGD). In the present study we focused on identifying the
ion channels or transporters that might underlie the different capabilities of these two astrocytic subpopulations to regulate
their volume during OGD. Using three-dimensional confocal morphometry, which enables quantification of the total
astrocytic volume, the effects of selected inhibitors of K
+ and Cl
2 channels/transporters or glutamate transporters on
astrocyte volume changes were determined during 20 minute-OGD in situ. The inhibition of volume regulated anion
channels (VRACs) and two-pore domain potassium channels (K2P) highlighted their distinct contributions to volume
regulation in HR-/LR-astrocytes. While the inhibition of VRACs or K2P channels revealed their contribution to the swelling of
HR-astrocytes, in LR-astrocytes they were both involved in anion/K
+ effluxes. Additionally, the inhibition of Na
+-K
+-Cl
2 co-
transporters in HR-astrocytes led to a reduction of cell swelling, but it had no effect on LR-astrocyte volume. Moreover,
employing real-time single-cell quantitative polymerase chain reaction (PCR), we characterized the expression profiles of
EGFP-positive astrocytes with a focus on those ion channels and transporters participating in astrocyte swelling and volume
regulation. The PCR data revealed the existence of two astrocytic subpopulations markedly differing in their gene
expression levels for inwardly rectifying K
+ channels (Kir4.1), K2P channels (TREK-1 and TWIK-1) and Cl
2 channels (ClC2).
Thus, we propose that the diverse volume changes displayed by cortical astrocytes during OGD mainly result from their
distinct expression patterns of ClC2 and K2P channels.
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Introduction
The generation of brain edema, ultimately leading to an
intracranial pressure increase and brain herniation, markedly
alters the course and treatment of cerebral ischemia. Among brain
cell types, astrocytes have been reported to contribute predomi-
nantly to edema formation. They support neuronal function and
provide for the maintenance of ionic and neurotransmitter
homeostasis under physiological conditions; however, they may
also contribute to the worsening of brain damage under
pathological conditions. The uptake of ions and amino acids
may turn into an excessive osmolyte influx leading to the
generation of edema, which in turn contributes to further ischemic
damage. Several transporters and ion channels have been
described as participating in astrocytic swelling (for a review, see
[1]). Astrocytic Na
+-dependent glutamate uptake, which is
responsible for the termination of synaptic transmission and helps
to protect neurons from the excitotoxic activity of glutamate, may
reverse as a consequence of the ionic dis-balance accompanying
energy depletion during severe ischemia and thus contribute to an
increase of extracellular glutamate concentrations [2]. Addition-
ally, K
+-Cl
2 (KCC) and Na
+-K
+-Cl
2 (NKCC) co-transporters, the
major regulators of neuronal and astrocytic Cl
2 and Na
+
gradients, have been found to participate in cell volume changes
under pathological conditions. Increased NKCC activity has been
shown to result in Na
+,K
+ and Cl
2 accumulation, thus markedly
contributing to astrocytic swelling [3], while KCCs, which are
responsible for ion efflux, are rather involved in regulatory volume
decrease (RVD) [4]. Nonetheless, a high extracellular concentra-
tion of K
+ ([K
+]o) may induce the reverse operation of KCCs and
thus contribute to cell swelling, as described in retinal Mu ¨ller cells
[5]. Furthermore, the depolarization of the astrocytic membrane
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+/K
+ ATP-ase inhibition results in excessive K
+ and Cl
2
influx via ion channels [6]. Despite the fact that a prominent role
in K
+ buffering has been suggested for the astrocytic Kir4.1
channel [7,8], two-pore domain K
+ (K2P) channels, especially
TWIKs and TREKs, have been shown to be responsible for glial
K
+ uptake [9], and their contribution to glial volume homeostasis
was described in Mu ¨ller cells [10]. The activation of K2P channels
in response to ischemia has been demonstrated in vitro by Buckler
and Honore [11] and the up-regulation of TREK-2 channels in
conjunction with extracellular glutamate clearance was demon-
strated in cultured rat astrocytes during anoxia/hypoglycemia by
Kucheryavykh and co-authors [12]. Concurrently, astrocytic
swelling is accompanied by RVD, which is also carried out by
Cl
2 and K
+ channels [13]. The main anion channels responsible
for Cl
2 and organic osmolyte efflux are volume-regulated anion
channels (VRACs), which play a predominant role in RVD.
However, an anion efflux via VRACs has also been shown to
contribute to further ischemic brain damage [14,15] and
moreover, VRACs have been reported to provide the anion
influx that results in neuronal swelling [16].
In our recent in situ studies we have demonstrated that cortical
astrocytes do not respond uniformly to hypoosmotic stress [17,18]
and that two differently responding groups of astrocytes – high
response- (HR-) astrocytes and low response- (LR-) astrocytes – are
present in the cortex of GFAP/EGFP mice [19] based on the
volume changes evoked by oxygen-glucose deprivation (OGD)
[20]. In the present study, we aimed to elucidate the basic
mechanisms potentially underlying the different ability of the two
astrocytic populations to regulate their volume in response to
OGD. We have focused on the role of chloride and potassium
channels/transporters and excitatory amino acid transporters in
astrocytic swelling during OGD. For the quantification of cell
volume, three-dimensional confocal morphometry has been
employed. Moreover, we have used real-time, single-cell quanti-
tative PCR (qPCR) to explore the gene expression profiles of
cortical GFAP/EGFP astrocytes with a focus on those ion
channels and transporters participating in astrocyte swelling and
volume regulation. We have used a similar approach to that of
Stahlberg and co-authors [21]; they have identified astrocytic
subpopulations in the mouse brain using single-cell qPCR
profiling.
Materials and Methods
Ethics Statement
All procedures involving the use of laboratory animals were
performed in accordance with the European Communities
Council Directive 24 November 1986 (86/609/EEC) and animal
care guidelines approved by the Institute of Experimental
Medicine ASCR Animal Care Committee on April 17, 2009;
approval number 85/2009.
Confocal 3D morphometry
Solutions. Artificial cerebrospinal fluid (ACSF) solution
contained (in mM): NaCl 122.0, KCl 3.0, CaCl2 1.5, MgCl2
1.3, Na2HPO4 1.25, NaHCO3 28.0, D-glucose 10.0 (pH 7.4, in
95% O2/5% CO2). Osmolality was confirmed to be 30065
mOsmol/kg with a vapor pressure osmometer (Vapro 5520,
Wescor Inc., Logan, USA). Oxygen–glucose deprivation (OGD)
was achieved by saturating glucose-free ACSF with 5% O2,5 %
CO2 and 90% N2 (ACSFOGD). All inhibitors and their
concentrations are listed in Table 1. DMSO, ethanol and
methanol, which were used for the preparation of inhibitor stock
solutions, did not affect astrocyte volume changes at their final
Table 1. List of used inhibitors.
c( mM) Targeted proteins in astrocytes
Transporters
DIOA 100** KCC [4]
[(dihydroindenyl)oxy]alkanoic acid
Bumetanide 100** NKCC [48]
3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid
DL-TBOA 100* EAAT1, 2 [53]
DL-threo-b-benzyloxyaspartic acid
Cl
2 channels
NPPB 100* Cl
2 channels, VRACs [24]
5-Nitro-2-(3-phenylpropylamino)benzoic acid
Tamoxifen 30*** VRACs [24]
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
DCPIB 30* VRACs [24]
4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid
K
+ channels
BaCl2 100 Kir channels [26]
BaCl2 1000 Kir, K2P channels [27]
Quinine 200** K2P channels [27]
KCC – K
+-Cl
2 co-transporter, NKCC – Na
+-K
+-Cl
2 co-transporter, EAAT – excitatory amino acid transporter, VRAC – volume-regulated anion channel, K2P – two-pore
domain potassium channel, Kir - inwardly rectifying potassium channel.
Stock solutions were dissolved at 1,0006final concentration in DMSO (*); ethanol (**) or methanol (***). BaCl2 was dissolved at 1 mM concentration in double-distilled
H2O( d d H 2O).
doi:10.1371/journal.pone.0029725.t001
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including inhibitors, were purchased from Sigma-Aldrich (St.
Louis, MO, USA). DL-TBOA was purchased from Tocris
Bioscience (Bristol, UK).
Brain slice preparation. Quantification of astrocyte volume
changes was carried out in acute brain slices of GFAP/EGFP mice
[19]. Thirty to forty-day-old male/female mice were anesthetized
with isoflurane followed by decapitation. Brains were dissected out
and placed into ice-cold oxygenated ACSF. Transverse slices
(400 mm) were cut using an HM650V vibratome (MICROM
International GmbH, Waldorf, Germany). The slices were kept in
continuously oxygenated ACSF, at room temperature (23–25uC),
for at least 1 hour before starting experiments. To estimate the
effect of each inhibitor on astrocytic swelling evoked by OGD, a
single astrocyte was recorded in one slice and slices from 2–3 mice
were used for each inhibitor.
Cell volume measurement and quantification. Changes
in total astrocytic volume were measured and quantified using
previously described method [17,18,20]. The slices were perfused
with ACSF or ACSFOGD (perfusion rate ,5 ml/min). To examine
the effect of inhibitors on astrocyte volume changes, they were
appliedduring40-minuteOGD.Allexperimentswereperformed at
room temperature (23–25uC). For cell volume quantification (Fig.
S1) we have selected only brightly fluorescent cells at an
approximate distance of ,30 mm from the slice surface. The
astrocytes were recorded as a set of two-dimensional (2D) sectional
images witha resolution of 102461024 pixels using a Leica TCS SP
system confocal microscope (Leica Germany) with a Leica 406
water immersion objective (0,8) HCX APO (Leica, Germany).
EGFP was excited by an Ar laser set at 488 nm, and the emitted
signal was recorded over the range of 510–552 nm using a TD488/
543/633 filter. Each three-dimensional (3D) image of the cell was
sectioned into 70–80 consecutive 2D images at a uniform spacing of
1 mm. Data were collected at 10 minute intervals. Image processing
and morphometric measurements were performed using the
program CellAnalyst developed at the Department of Cellular
Neurophysiology, Institute of Experimental Medicine, Prague,
Czech Republic [18].
Statistics. Changes in total astrocyte volume are presented as
the mean 6 SEM. Statistical significance was determined by a
two-tailed unpaired Student’s t-test. Differences between the
groups were considered statistically significant when p,0.05,
very significant p,0.01, and extremely significant p,0.001.
Single-cell gene expression profiling
Preparation of cell suspensions from the cortex of GFAP/
EGFP mice. GFAP/EGFP transgenic mice (30 days old) were
deeply anesthetized with sodium pentobarbital (PTB, 100 mg/kg,
i.p.), and perfused transcardially with cold (4–8uC) isolation buffer
containing (in mM): NaCl 136.0, KCl 5.4, Hepes 10.0, glucose
5.5, osmolarity 29063 mOsmol/kg. The forebrain was isolated by
the removal of the olfactory lobes, cerebellum, and midbrain/
hindbrain structures by dissection. To isolate the cerebral cortex,
the brain was sliced in 1 mm coronal sections using a vibrating
microtome HM650V (MICROM International GmbH, Walldorf,
Germany), and the cerebral cortex was carefully dissected away
from the ventral white matter tracks. The tissue was incubated
with continuous shaking at 37uC for 90 minutes in 5 ml of a
papain solution (20 U/ml) and 0.2 ml DNAase (both
Worthington, Lakewood, NJ) prepared in isolation buffer. After
papain treatment the tissue was mechanically dissociated by gentle
trituration using a 1 ml pipette. Dissociated cells were layered on
top of 5 ml of Ovomucoid inhibitor solution (Worthington) and
harvested by centrifugation (1406g for 6 minutes). This method
routinely yielded ,1.5–2 million cells per mouse forebrain.
Collection of single EGFP-positive cells. Dissociated cells
were sorted using flow cytometry (BD FACSCalibur); they were
kept on ice throughout the sorting procedure. Cell aggregates were
removed by filtering with a 30 nm cell strainer (Becton Dickinson,
USA). The flow cytometry instrument was manually calibrated to
deposit single cells in the centre of each collection tube. Propidium
iodide was added to the suspension of cells for checking viability.
Single cells were collected into 96-well plates (Life Technologies,
Czech Rep.) containing 5 ml nuclease-free water with bovine
serum albumin (1 mg/ml, Fermentas, Biogen, Czech Rep.) and
20 U RNAseOut (Life Technologies, Czech Rep.) per well. The
plates were then placed on a pre-cooled rack. The astrocytes were
collected based upon their positivity for EGFP and their viability.
Plates with collected cells were immediately frozen at 280uC.
cDNA synthesis. A modified protocol of A. Stahlberg [21]
was used for cDNA synthesis. SuperScript III RT (Life
Technologies, Czech Rep.) was used for reverse transcription.
Lysed single cells in 5 ml water containing 0.5 mM dNTP
(Promega, Germany), 1.0 mM oligo(dT15) (Invitrogen) and
1.0 mM random hexamers (Invitrogen) were incubated at 70uC
for 5 min. 50 mM Tris–HCl, 75 mM KCl, 3 mM MgCl2,5m M
dithiothreitol, 20 U RNaseOut and 100 U SuperScript III (all
Invitrogen; final concentrations) were added to a final volume of
10 ml. Reverse transcription was performed at 25uC for 5 min,
50uC for 60 min, 55uC for 10 min and terminated by heating to
70uC for 15 min. All samples were diluted to 40 ml with water
before qPCR.
Primer design and optimization of assays. Primers were
designed using BeaconDesigner software (version 7.91, Premier
Biosoft International). All primers except those for Cspg4 and Nkcc1
were designed to span an intron to avoid amplification of genomic
DNA. BLAST (Basic Local Alignment Search Tool) searches
revealed no pseudogenes. The primer sequences are shown in
Table S1. All assays of single cells were optimized so as to not
generate primer dimers before cycle 45, to have a PCR efficiency
of at least 90%, and to amplify all known splice forms documented
by the National Center for Biotechnology Information (NCBI).
Calibration curves with purified PCR products (QIAquick PCR
Purification Kit; Qiagen, Germany) were used to establish the
linearity of the assays. The formation of the correct PCR products
was confirmed by electrophoresis on 20 g/L agarose gels for all
assays and by melting-curve analysis of all samples. Five individual
cells per assay were tested, and no genomic DNA amplification
was observed.
qPCR. A Biorad CFX384 (Biorad, Czech Rep.) was used for
all qPCR measurements. To each reaction (10 ml) containing iQ
SYBR Green Supermix (BioRad) and 300 nM of each primer
(EastPort, Czech Rep.), we added 3 ml diluted cDNA. The
temperature profile was 95uC for 3 min followed by 50 cycles of
amplification (95uC for 15 s, 60uC for 15 s and 72uC for 20 s). All
samples were analyzed by melting curve analysis.
Data processing and statistics. For all assays the limit of
detection (LOD) was assumed to be the highest Cq (quantification
cycle) value measured reflecting the expected product based on
melt curve analysis. All Cq values that were above the limit of
detection and hence were reflecting the formation of aberrant
products, and any missing data, were replaced by the Cq at the
limit of detection +1. The correction was performed separately for
each gene and effectively corresponds to assigning a concentration
to the off-scale measurements that is 50% of the concentration we
reliably detect. Cq values were converted to relative quantities and
transformed to a log scale [22].
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nen self-organizing maps were calculated using GenEx software
(ver. 5.3, MultiD, Sweden). The expression of each gene was
mean-centred for profiling analysis with multivariate methods.
Dendrograms were calculated using Ward’s algorithm and
Euclidean distance measure. Spearman correlation coefficients
were calculated for all gene pairs. Because of the significant
number of off-scale data that were corrected, the distribution of
data was not necessarily Gaussian, and non-parametric statistical
tests were used to assess significance. The expression levels
measured in groups of cells were compared using the non-
parametric Kruskal-Wallis test with Dunn’s post-test. For
Kohonen self-organizing maps (SOMs) and potential curve
analysis, autoscaled expression values were used to give all genes
equal weight in the clustering algorithms. The parameters used for
the Kohonen SOMs were: 3x1 map, 0.10 learning rate, 2–3
neighbors and 10000 iterations. The calculated clusters did not
depend on the parameters’ settings.
Results
Astrocyte heterogeneity has been described previously as
morphological differences, distinct functional properties and
variations in the expression of receptors, ion channels and
transporters [23]. In our previous study [20] we described two
astrocytic subpopulations in the cortex of GFAP/EGFP mice
differing in their volume changes induced by OGD. One
subpopulation, referred to as high response-astrocytes (HR-
astrocytes), markedly increased their total cell volume when
exposed to OGD, while only small volume changes were evoked in
the second subpopulation, referred to as low response-astrocytes
(LR-astrocytes). Both subpopulations were morphologically iden-
tical, displayed passive currents and expressed EAAT1 and
EAAT2 transporters. Here, we focus on elucidating the differences
between these two subpopulations that might originate from the
diverse functioning/expression of ion channels and transporters
that are involved in astrocytic swelling and cell volume regulation.
We have employed a wide range of transporter- and ion channel-
inhibitors (Table 1) to study their effects on astrocyte volume
changes in situ evoked by OGD.
Astrocyte swelling evoked by oxygen-glucose
deprivation
To examine the effect of inhibitors on acute astrocytic swelling,
brain slices were exposed to 40-minute OGD. The values of total
astrocyte volume obtained during 40-minute OGD in the absence
of any inhibitor were used as control values and compared to those
obtained in the presence of inhibitors. The astrocyte volume at
t=0 was set to 100%, and the volume changes were expressed
relative to this baseline as an increase in percentage. HR- and LR-
astrocytes were classified using the same criteria as described
previously [20]. Briefly, if the total cell volume increase was less
than 10% (LR-astrocytes), the relative changes in total volume, cell
soma volume and the volume of the processes were similar. If the
total cell volume increase was greater than 10% (HR-astrocytes),
the swelling of the cell processes exceeded the swelling of the soma.
The total cell volume (V) of HR-astrocytes (n=13) increased to
122.161.4% after 20 minutes and to 135.962.6% after 40 min-
utes of OGD. LR-astrocytes (n=8) increased their volume to
108.460.8% after 20 minutes and to 117.662.1% after 40 min-
utes of OGD (Fig. 1, 2, 3 top). The effects of inhibitors were
studied as follows: brain slices were first exposed to OGD alone for
20 minutes, followed by a 20 minute application of ACSFOGD
together with an inhibitor (Fig. S2). Using this approach, an
individual cell could be classified as either an HR- or LR- astrocyte
based on its volume changes during the first 20 minutes. In order
to evaluate the effect of inhibitors on astrocytic swelling, volume
changes were evaluated in each cell individually and expressed as a
percent cell volume increase/decrease related to the volume
obtained after the first 20 minutes of OGD, which was set as 0%
(Fig. 1, 2, 3 bottom).
Inhibition of glutamate and K
+-Cl
2 transporters reduces
the astrocytic swelling induced by OGD in both
subpopulations, while inhibition of Na
+-K
+-Cl
2
co-transporters affects only HR-astrocytes
The disruption of ionic and excitatory amino acid (EAA)
homeostasis that occurs during cerebral ischemia results in
enhanced glutamate/K
+ uptake by astrocytic transporters, leading
to marked volume changes in astrocytes during ischemia [1]. In
order to determine whether these transporters underlie the
differences in volume changes between HR-/LR-astrocytes, we
tested the effect of DL-TBOA, an inhibitor of the excitatory amino
acid transporters EAAT1 and EAAT2, bumetanide, an inhibitor of
Na
+-K
+-Cl
2 co-transporters (NKCCs), and DIOA, an inhibitor of
K
+-Cl
2 co-transporters (KCCs), on the astrocyteswelling evoked by
OGD (for concentrations see Table 1). The application of DL-
TBOA led to a significant volume decrease in both astrocytic
subpopulations (Fig. 1A); however, the course of inhibition was
slightly different. While HR-astrocyte swelling remained unaffected
duringthefirst10 minutes, itdecreased by6.9% after20 minutes of
ACSFOGD and DL-TBOA co-application (n=6). In LR-astrocytes
swelling wasreduced already after10 minutes,andafter20 minutes
theswellingwasreduced by10.4%(n=6).Similarly, the inhibitorof
KCCs - DIOA - inhibited cell swelling in both astrocyte groups
(Fig.1B).A 20 minuteapplication ofACSFOGDandDIOA reduced
cell swelling by 7.1% in HR-astrocytes (n=9) and by 10.2% in LR-
astrocytes (n=9). On the other hand, the inhibition of NKCCs by
bumetanide led to the reduction of swelling in HR-astrocytes (by
7.0% after 20 minute ACSFOGD and bumetanide co-application;
n=10), while in LR-astrocytes the application of bumetanide did
not significantly alter the extent of cell swelling (n=10; Fig. 1C). In
summary, the ion influx via NKCCs significantly contributed to
HR-astrocyte swelling during OGD, while it was not involved in the
volume changes observed in LR-astrocytes.
Inhibition of volume-regulated anion channels or two-
pore domain K
+ channels during OGD reveals differences
between HR- and LR-astrocytes
Since in many cell types, including astrocytes, VRACs are the
predominant channels activated by swelling [13], we have
examined the effects of three VRAC inhibitors – NPPB, tamoxifen
and DCPIB (for concentrations see Table 1). A non-selective
inhibitor of anion channels, NPPB had an opposite effect on the
two astrocytic subpopulations (Fig. 2A). The swelling of HR-
astrocytes was decreased by 11.6% after 20 minutes of ACSFOGD
and NPPB co-application (n=6), while in LR-astrocytes the
swelling was first reduced by 4.2% after 10 minutes and then it
rather increased (n=9). Similarly, tamoxifen and DCPIB also had
a diverse effect on HR-/LR-astrocytes. Tamoxifen reduced the
HR-astrocyte swelling by 6.2% after 20 minutes of its application
(n=10) and the DCPIB application led to the swelling reduction of
9.0% after 20 minutes (n=8). On the other hand, the LR-
astrocyte swelling was not appreciably affected by Tamoxifen
(Fig. 2B), whereas DCPIB application led to their additional
swelling (Fig. 2C). Moreover, the block of HR-astrocyte swelling
by NPPB was more effective than that induced by the other
Distinct Volume Regulation in Cortical Astrocytes
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inhibitor as reported previously by Abdullaev and co-authors [24],
suggesting that more types of chloride channels are involved in
HR-astrocyte swelling. In summary, DCPIB, which is currently
the most selective inhibitor of VRACs known, reduced the swelling
induced by OGD in HR-astrocytes, while in LR-astrocytes this
inhibitor caused their additional swelling.
In view of previous findings that the main K
+ channels expressed
in mature astrocytes are Kir4.1 and two-pore domain channels
[25,26], we have examined the effect of BaCl2 and quinine (for
concentrations see Table 1) on the volume changes of HR-/LR-
astrocytes during OGD. The application of 100 mMB a C l 2, which
has been shown to preferentially inhibit Kir channels [26], led to an
additionalswellingafter20 minutesofOGDinbothsubpopulations
of astrocytes. The swelling increased by 6.6% in HR-astrocytes
(n=8) and by 7.7% in LR-astrocytes (n=10; Fig. 3A). Conversely,
1 mM BaCl2, used as a blocker of both Kir and K2P channels [27],
completely inhibited the swelling of HR-astrocytes (9.9% reduction
after 20 minutes; n=7), while in LR-astrocytes it rather led to an
additional swelling (not significant, n=13; Fig. 3B). Equally, the
application ofquinine slightly reduced the swelling of HR-astrocytes
(not significant; n=5), while markedly increased the swelling of LR-
Figure 1. Inhibitors of glutamate transporters and K
+-Cl
2 co-transporters reduce the OGD-induced swelling in both astrocytic
subpopulations. The effect of 100 mM DL-TBOA, an inhibitor of excitatory amino acid transporters (A), 100 mM DIOA, an inhibitor of K
+-Cl
2 co-
transporter (B), and 100 mM bumetanide, an inhibitor of Na
+-K
+-Cl
2 co-transporter (C). A–C top: Time course of volume changes in HR-astrocytes
(filled circles) and LR-astrocytes (empty circles) during 40-minute OGD (control) and during 20-minute OGD followed by 20-minute OGD with the
application of an inhibitor in HR-/LR-astrocytes (filled/empty triangles). A–C bottom: The effect of inhibitors was evaluated in each individual cell
and expressed as the percent cell volume increase/decrease related to the maximal volume after 20-minute OGD, which was set as 0%. Note that the
application of DL-TBOA and DIOA led to a swelling reduction in both HR- and LR- astrocytes, while bumetanide only affected the swelling in HR-
astrocytes. Asterisks indicate significant differences from controls (p,0.05 (*, significant), p,0.01 (**, very significant), p,0.001 (***, extremely
significant)).
doi:10.1371/journal.pone.0029725.g001
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the inhibition of Kir channels revealed that they contribute
predominantly to the efflux of K
+ in both astrocytic subpopulations.
On the other hand, the inhibition of K2P channels disclosed their
participation in K
+ uptake in HR-astrocytes, while in LR-astrocytes
they rather contribute to K
+ efflux.
The presence of two distinct populations is not linked to
gender or location in the cortical layers
Since the sensitivity of astrocytes to OGD might be influenced
by their location within the CNS, we quantified the incidence of
HR-/LR- astrocytes based on their position in the cortical layers.
The distribution of astrocytes between the two groups in the
different cortical layers was as follows: I layer – 46% HR, 54% LR
(n=46), II–III layers – 41% HR, 59% LR (n=113), IV–VI layers
– 48% HR, 52% LR (n=133). Although females have been shown
to be more resistant to ischemic injury than males in clinical
studies as well as in animal models [28], gender does not underlie
the existence of two astrocytic groups with a different sensitivity to
ischemic conditions. In females, 45% of measured cells were
classified as HR- and 55% as LR-astrocytes (total number of cells
n=193); similarly in males, 49% of cells belonged to HR- and
51% to LR- astrocytes (n=168). In conclusion, neither the
location of astrocytes in the cortical layers, nor the gender of the
Figure 2. Inhibitors of Cl
2 channels differently affect OGD-induced swelling in HR-and LR-astrocytes. The effect of 100 mM NPPB, a non-
specific inhibitor of chloride channels (A), 30 mM Tamoxifen (B) and 30 mM DCPIB (C), inhibitors of volume regulated anion channels. A–C top: Time
course of volume changes in HR-astrocytes (filled circles) and LR-astrocytes (empty circles) during 40-minute OGD (control) and during 20-minute
OGD followed by 20-minute co-application of ACSFOGD plus an inhibitor in HR-/LR-astrocytes (filled/empty triangles). A–C bottom: The effect of the
inhibitors was evaluated in each individual cell and expressed as the percent cell volume increase/decrease related to the maximal volume after 20-
minute OGD, which was set as 0%. Note that in HR-astrocytes the application of VRAC inhibitors (Tamoxifen and DCPIB) reduced the swelling induced
by OGD, while in LR-astrocytes the application of DCPIB resulted in an additional swelling. Asterisks indicate significant differences from controls
(p,0.05 (*, significant), p,0.01 (**, very significant), p,0.001 (***, extremely significant)).
doi:10.1371/journal.pone.0029725.g002
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in their response to OGD (Fig. S3).
Single-cell gene expression profiling reveals astrocyte
heterogeneity in the cortex of GFAP/EGFP mice
We have also considered that the different abilities of astrocytes
to regulate their volume might originate from distinct cellular
phenotypes characterized by ion channel/transporter expression
profiles. Based on pharmacological analyses, we have selected
genes encoding astrocytic channels and transporters that could be
responsible for the divergent volume regulation in cortical
astrocyte subpopulations and performed quantitative single-cell
PCR analyses. EGFP-positive cells were collected using fluores-
cence-activated cell sorting (FACS). Collected brightly fluorescent
astrocytes expressed high mRNA levels of Eaat1, Eaat2 and Aqp4,
which code the typical astrocytic markers: EAAT transporters 1
and 2 and AQP4 water channels [29]. EGFP-positive cells
expressing genes typical of NG2 glia, namely Pdgfr and Cspg4
(coding PDGFa receptors and chondroitin sulfate proteoglycan 4),
were excluded from the analyses. The first round of screening, in
which all genes listed in Table S1 were tested, revealed significant
differences in gene expression among cortical astrocytes. For
further analyses, we have chosen 16 genes (Table S1) that showed
marked differences in their expression levels during the first round
Figure 3. Inhibitors of K
+ channels have an opposite effect on HR-/LR-astrocytes when applied during OGD. The effect of 100 mM BaCl2
(A), an inhibitor of inwardly rectifying potassium channels, 1 mM BaCl2 (B) and 200 mM Quinine (C), inhibitors of two-pore domain potassium
channels. A–C top: Time course of volume changes in HR-astrocytes (filled circles) and LR-astrocytes (empty circles) during 40-minute OGD (control)
and during 20-minute OGD followed by 20-minute co-application of ACSFOGD plus an inhibitor in HR-/LR-astrocytes (filled/empty triangles). A–C
bottom: The effect of inhibitors was evaluated in each individual cell and expressed as the percent cell volume increase/decrease related to the
maximal volume after 20-minute OGD, which was set as 0%. Note that the application of 1 mM BaCl2 or Quinine inhibited swelling in HR-astrocytes,
while in LR-astrocytes it had the opposite effect. In contrast, the application of 100 mM BaCl2 had the same effect in both groups of astrocytes.
Asterisks indicate significant differences from controls (p,0.05 (*, significant), p,0.01 (**, very significant), p,0.001 (***, extremely significant)).
doi:10.1371/journal.pone.0029725.g003
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independent experiments (I and II). In experiment I, the
expression profiles of Nkcc1, Eaat1-2, Vdac1-3, Aqp4, Clcn2 and
Kcc1 were determined in 103 astrocytes. The numbers of astrocytes
positive for individual genes are listed in Table S2. At first, we
looked for correlations between the genes using Spearman’s
correlation. The correlation coefficient is a value between 21 and
1, where 1 reflects a perfect positive correlation, 21 reflects a
perfect negative correlation and 0 indicates no correlation.
Significant positive correlations were found between Eaat1 –
Eaat2, Eaat1 – Aqp4, Eaat1 – Vdac1, 2, 3, Eaat2 – Aqp4 and Eaat2 –
Vdac2. The correlation coefficients for genes tested in experiment I
are listed in Table S4. We have employed three independent
analyses: principal component analysis (PCA) that enables the
visualization of multidimensional data in a two- or three-
dimensional plot [30], hierarchical clustering and Kohonen SOMs
(Fig. 4 and 5). Based on these three independent mathematical
algorithms, we have identified two subpopulations of astrocytes –
subpopulation 1 and subpopulation 2 – that differ in their gene
expression profiles. In experiment I (Fig. 4), both subpopulations
expressed comparable levels of Eaat1-2, Aqp4, Nkcc1, Kcc1 and
Vdac1-3; however, in subpopulation 2 a markedly reduced
expression of Clcn2 was detected. In experiment II, the expression
of Eaat1-2, Kcnj2, 10, 16, Kcnk1, 2, 10 and Clcn2 was measured in
52 individual astrocytes. The numbers of astrocytes positive for
individual genes after dividing the cells into two astrocytic
Figure 4. Experiment I: gene expression profiling of distinct astrocytic subpopulations. A: Bar plot with SEM for all the expressed genes;
significant differences are indicated with asterisks (p,0.05 (*), p,0.01 (**), p,0.001 (***). B: Principal component analysis. The identification of 2
astrocytic subpopulations is along the first principal component, which accounts for most of the variation in the measured data. C: Clustering of
astrocytes using Kohonen SOMs. The expression levels of all genes were mean-centered. Each dot represents one cell. D: Dendrogram based on all
astrocytic genes. The y-axis shows the distance between groups.
doi:10.1371/journal.pone.0029725.g004
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levels from independent experiments and to follow the same
astrocytic subpopulations that were identified in experiment I, we
have analyzed Eaat1, Eaat2 and Clcn2 in both experiments.
Significant positive correlations were found between Eaat1 – Eaat2
and Eaat2 – Kcnj10. Interestingly, significant negative correlations
were found between Kcnk2 – Kcnk1 and Clcn2 – Kcnk1, which means
that the majority of cells expressing Kcnk1 (the gene encoding
TWIK-1) do not express Kcnk2 and Clcn2 (encoding TREK-1 and
ClC2 channels). The Spearman correlation coefficients for the
genes tested in experiment II are listed in Table S5. In experiment
II (Fig. 5), in addition to Clcn2, Kcnj10, Kcnk1 and Kcnk2 were also
identified as genes separating the two astrocytic subpopulations.
While Kcnj10 and Kcnk1 were highly expressed in subpopulation 2,
their expression in subpopulations 1 was significantly lower. On
the other hand, Kcnk2 was highly expressed in subpopulation 1,
while it was almost absent in subpopulation 2.
In summary, we found two astrocytic subpopulations in the
cortex of GFAP/EGFP mice related to distinct expression profiles
of Clcn2, Kcnj10 and Kcnk1, 2 (genes encoding ClC2, Kir4.1,
TWIK-1 and TREK-1).
Discussion
In the present study we have demonstrated that the two
previously described cortical astrocytic populations – HR- and
Figure 5. Experiment II: gene expression profiling of distinct astrocytic subpopulations. A: Bar plot with SEM for all the expressed genes;
significant differences are indicated with asterisks (p,0.05 (*), p,0.01 (**), p,0.001 (***). B: Principal component analysis. The identification of 2
astrocytic subpopulations is along the first principal component, which accounts for most of the variation in the measured data. C: Clustering of
astrocytes using Kohonen SOMs. The expression levels of all genes were mean-centered. Each dot represents one cell. D: Dendrogram based on all
astrocytic genes. The y-axis shows the distance between groups.
doi:10.1371/journal.pone.0029725.g005
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2 and K
+ channel
inhibitors when applied during OGD. In accordance with the
pharmacological experiments, quantitative single-cell PCR profil-
ing revealed that cortical astrocytes are heterogeneous with respect
to the gene expression profiles of the ion channels/transporters
that participate in their volume regulation. We distinguished
subpopulation 1, which is characterized by high gene expression
levels of Cl
2 channels and K
+ channels, namely ClC2 and TREK-
1, and subpopulation 2, displaying high gene expression levels of
K
+ channels – Kir4.1, TWIK-1. As we hypothesize that the
diverse HR- and LR-astrocyte swelling might be a consequence of
different gene expression levels for ClC2 and TREK-1, both
contributing strongly to astrocyte volume regulation, we propose a
correlation of subpopulation 1 with LR-astrocytes and subpopu-
lation 2 with HR-astrocytes. Their proposed correlation with the
HR-/LR- classification scheme is summarized in Figure 6.
The most striking dissimilarity between HR- and LR- astrocytes
was found during the inhibition of K2P channels by 1 mM BaCl2
and 200 mM quinine. Barium chloride (1 mM), which was shown
to block the inwardly rectifying K
+ channel TWIK-1 [27],
markedly reduced the swelling of HR-astrocytes, thus suggesting
that TWIK-1 channels contribute to K
+ influx into HR-astrocytes.
In contrast, quinine, which inhibits the outwardly rectifying K2P
channel TREK-1, increased the swelling of LR-astrocytes, thus
implying that K2P channels provide K
+ extrusion in LR-astrocytes.
Since polymodal TREK channels are activated by mechanical
stress/cell swelling, their role in RVD is highly possible [31].
These data are also in agreement with previous studies of
Skatchkov and co-authors [10] in retinal Mu ¨ller glia. Moreover,
our quantitative single-cell PCR analysis revealed distinct
astrocytic subpopulations: subpopulation 1 expressing extremely
high levels of Kcnk2 (a gene for TREK-1) and subpopulation 2
expressing high levels of Kcnk1 (a gene for TWIK-1). Combining
our pharmacological and PCR data, we propose that TREK-1
channels are uniquely expressed in LR-astrocytes and thus
contribute to their efficient cell volume regulation during OGD
by providing K
+ efflux. On the other hand, HR-astrocytes strongly
express TWIK-1, which is responsible for enhanced K
+ uptake
and their swelling. A similar heterogeneity in K2P channel
expression was demonstrated in hippocampal astrocytes [26].
Unequal TWIK-1/TREK-1 expression levels might originate
from the local environment of each astrocyte in the cortex, as
proposed in Fig. 7. We hypothesize that HR-astrocytes comprise
cells locally exposed to a high extracellular K
+ concentration
([K
+]o), thus predominantly expressing inwardly rectifying chan-
nels for effective K
+ uptake. LR-astrocytes, in contrast, might
receive K
+ as a consequence of spatial buffering and release it into
the ECS. Apparently, K2P channels play an important role during
ischemia as demonstrated by Kucheryavykh and co-authors [12],
who showed the involvement of TREK-2 channels in response to
anoxia/hypoglycemia in cultured rat astrocytes. Our present
findings demonstrate the involvement of TREK-1 rather than
TREK-2 in astrocytic swelling during OGD; however, such
discrepancies might originate from the different properties of
cultured astrocytes isolated from 1-day-old rats [12] and those in
brain slices of 30-day-old mice, and moreover, from employing
different models of brain injury. Nonetheless, in our recent work,
Pivonkova and co-authors [25] described the increased expression
of TREK-1 in hippocampal astrocytes in the CA1 region following
global cerebral ischemia in vivo.
Furthermore, we have demonstrated that in HR- and LR-
astrocytes the inhibition of Kir channels led to additional cell
swelling, which suggests that Kir channels contribute rather to K
+
efflux than K
+ uptake after 40 minute OGD. This is in line with
data demonstrating the participation of Kir4.1 in RVD
[32,33,34,35]. In contrast to the comparable effect of a Kir
channel inhibitor (100 mM BaCl2) on the extent of cell swelling in
both astrocytic subpopulations, we found a significantly increased
expression of Kcnj10 (encoding Kir4.1) in subpopulation 2 that
comprises HR-astrocytes. In general, an astrocyte is considered as
a multifunctional unit in which the role of Kir channels can differ
in the various plasma membrane regions of a given cell, providing
K
+ uptake at sites facing the synapses and K
+ release from
astrocyte endfeet that contact blood vessels [36]. Based on this
assumption, changes in total astrocytic volume thus reflect both K
+
uptake as well as K
+ release. As blocking Kir4.1 channels by
100 mM barium resulted in a similar effect on LR- and HR-
Figure 6. Two astrocytic subpopulations differing in the gene
expression levels of K
+/Cl
2 channels. We propose a correlation of
subpopulation 1 with LR-astrocytes and subpopulation 2 with HR-
astrocytes due to the diverse gene expression levels for ClC2 and TREK-
1, which are responsible for K
+ and Cl
2 efflux and thus contribute to cell
volume regulation. Ion channels outlined with dashed line indicate their
low gene expression levels. Arrows indicate the proposed direction of
ion/EAA fluxes through the channels/transporters during OGD based on
the effect of the relevant inhibitors. AQP4 – aquaporin channel (subtype
AQP4), ClC2 - chloride channel (subtype ClC2), EAAT – excitatory amino
acid transporter (subtypes EAAT1 and EAAT2), HR – high response
astrocyte, TWIK1 and TREK1 – two-pore domain potassium channels
(subtypes TWIK-1, TREK-1), KCC1 – K
+-Cl
2 co-transporter (subtype
KCC1), Kir4.1 – inwardly rectifying potassium channel, LR – low response
astrocyte, NKCC1 – Na
+-K
+-Cl
2 co-transporter (subtype NKCC1).
doi:10.1371/journal.pone.0029725.g006
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proportion of Kir4.1 channels that provide K
+ uptake (causing
astrocytic swelling) and those providing K
+ release (causing
astrocytic shrinkage) are comparable. This might ultimately lead
to the similar impact of Kir4.1 inhibition on astrocyte volume
despite the observed differences in Kcnj10 expression between the
two subpopulations. We hypothesize that the high expression of
Kcnj10 in HR-astrocytes may mirror the increased requirements for
Kir4.1 channel densities on HR-astrocyte membranes as these cells
might be exposed to higher local extracellular concentration of K
+
than are LR-astrocytes, thus providing significantly greater K
+
uptake/K
+ release. This accords well with our previous findings, in
which we described the presence of cortical astrocytes differing in
Kir4.1 levels based on immunohistochemistry [20]. Nonetheless, a
detailed analysis of different cellular compartments, such as
astrocytic processes in the vicinity of neuronal synapses or those
neighboring blood vessels, might elucidate the relative contribution
of K
+ influx and efflux to astrocyte volume with respect to the local
uptake/release provided by Kir4.1 channels. Additionally, both
types of astrocytes express Kcnj16 (encoding Kir5.1), and thus the
ratio between the Kir4.1 homomer and the Kir4.1/Kir5.1
heteromer might play an important role in K
+ uptake as well
[36]. Finally, we also cannot exclude the possibility that 100 mM
barium may not have been sufficient to fully block the K
+ fluxes
carried by Kir4.1 in brain slices that are 400 mm thick.
Similarly to K2P channel inhibition, we found significant
diversity between HR- and LR-astrocytes when chloride channels
were inhibited using three different inhibitors. The inhibition of
VRACs by tamoxifen and DCPIB led to a marked reduction of
swelling in HR-astrocytes, which is in contrast to the proposed role
of VRACs in RVD [37,38]. Nevertheless, these channels have
been shown to be responsible for chloride influx leading to
persistent neuronal swelling during a prolonged excitotoxic insult
[16]. On the other hand, in LR-astrocytes the application of
Tamoxifen during OGD caused no volume changes. Nevertheless,
when DCPIB, so far the most specific known inhibitor of VRACs,
was applied, a significant increase in astrocyte volume was
detected. We hypothesize that LR-astrocytes efficiently regulate
their volume by VRACs, while HR-astrocytes might be more
ischemia-affected cells, in which volume regulation is suppressed.
As expected, the application of NPPB, a non-selective anion
channel blocker, led to the inhibition of swelling in both HR- and
LR-astrocytes during OGD, demonstrating that different chloride
channel types might be responsible for Cl
2 movement leading to
astrocytic swelling during OGD. Since the molecular structure of
VRACs has not yet been characterized [39], we performed gene
expression profiling of anion/chloride channels possibly involved
in astrocytic volume changes, such as plasmalemmal voltage-
dependent anion channels (VDAC1-3) and chloride channels
ClC2-10. Interestingly, we found marked differences in the
expression levels of Clcn2 (a gene for the ClC2 channel), which
has been reported to be activated by cell swelling [39]. Clcn2 is
highly expressed only in astrocytic subpopulation 1 (comprising
LR-astrocytes), thus possibly contributing to their increased ability
to regulate their cell volume.
Since it has been demonstrated that some ion channels are co-
expressed in certain regions of the astrocytic plasma membrane,
such as the endfeet [8,26,27,40], the importance of membrane
protein interactions that might occur between different membrane
units devoted to extracellular K
+ buffering and water homeostasis
should also be considered. Kir channels and AQP4 water channels
are among the first candidates for such interactions (specifically
Kir4.1), as demonstrated previously [41,42]; however, regulatory
volume decrease and volume homeostasis in astrocytes can also
involve the co-localization/interaction of transient receptor
potential vanilloid-4 (TRPV4) channels and AQP4 water channels
occurring in a Ca
2+2dependent manner, as demonstrated by
Benfenati and co-authors [43]. Despite the fact that we found
comparable Aqp4 expression in both astrocytic subpopulations, our
preliminary data also revealed marked differences in Trpv4 levels
in cortical astrocytes of EGFP/GFAP mice (unpublished data), a
finding that accords well with a previously published study on
primary cultures of cortical astrocytes in which only a certain
subpopulation of astrocytes (,60%) responded to a TRPV4
agonist or hypoosmotic stress [44]. However, further studies are
necessary to clarify the role of TRPV4 channels in the diverse
volume regulation of the two astrocytic subpopulations.
Finally, the inhibition of Na
+-K
+-Cl
2 co-transporter also
revealed differences between the two astrocytic populations. In
HR-astrocytes we observed a marked reduction of swelling
following bumetanide application during OGD, while the volume
of LR-astrocytes remained unaffected. Our observations in HR-
astrocytes are in agreement with those describing the involvement
of NKCCs in astrocyte swelling and their contribution to cytotoxic
edema [45–49]. The absence of a bumetanide effect on volume
changes in LR-astrocytes might be explained by low NKCC
protein levels, which were described by Yan and co-authors [50].
They found only a weak expression of NKCC1 in adult rat cortical
astrocytes, while stronger expression was detected in perivascular
astrocytes. Nevertheless, our PCR analysis did not reveal
significant differences in the gene expression levels of Nkcc1
among cortical astrocytes, and the overall expression levels were
quite low in both astrocytic subpopulations.
No differences between LR- and HR-astrocytes were found
during the inhibition of K
+-Cl
2 co-transporters or the Na
+-
dependent glutamate transporters EAAT1 (GLAST) and EAAT2
(GLT-1). KCC co-transporters contribute to the OGD-induced
cell swelling in both subpopulations and accordingly no differences
in the gene expression levels were found between subpopulation 1
Figure 7. Proposed K
+ movement from HR- to LR-astrocytes
during OGD. HR-astrocytes exposed to higher [K
+]o take up K
+ (by K2P
channels or co-transporters), which is either released via Kir channels or
redistributed through the astrocytic syncytium and then extruded by Kir
and K2P channels in LR-astrocytes. HR – high response astrocyte, LR –
low response astrocyte, N – neuron, K2P – two-pore domain potassium
channel, Kir – inwardly rectifying potassium channel, GJ – gap junction.
doi:10.1371/journal.pone.0029725.g007
Distinct Volume Regulation in Cortical Astrocytes
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e29725and 2. The participation of KCCs in K
+/Cl
2 uptake under
pathological conditions has been suggested previously in studies
performed in the chicken retina [5]. Similarly, a block of
glutamate co-transporters did not reveal differences between
HR- and LR-astrocytes. In both HR- and LR-astrocytes,
glutamate transporters contribute to the cell volume increase,
which is in accordance with previous studies [51,52].
We have proposed that differences in the extent of astrocytic
swelling during OGD may be due to distinct ion channel and
transporter expression. However, the possibility that HR- and LR-
astrocytes face high/low [K
+]o and excitatory amino acid
concentrations that could trigger distinct mechanisms of cell
swelling and cell volume regulation has to be also considered.
Although we have shown that their location in the cortical layers
does not affect the extent of volume changes during OGD, we
cannot rule out that the different volume regulation of astrocytes
might partially correlate with their contact with different types of
synapses or neurons with different sensitivity to ischemia. Since the
application of inhibitors on acute brain slices unquestionably
affects all cell types, we cannot overlook their inhibitory effect on
neurons. As the inhibition of EAATs, KCCs, VRACs and K
+
channels led to the reduction of HR-astrocyte swelling, we suggest
that the effect of the inhibitors might be partially achieved by a
block of K
+ and EAA efflux from neurons, resulting in decreased
astrocytic uptake.
Taken together, our results describe astrocytic subpopulations
differing in their gene expression levels of K
+ and Cl
2 channels,
which participate in astrocyte swelling as well as their volume
regulation. To the best of our knowledge, this is the first study
showing astrocyte heterogeneity in the cortex with respect to
distinct expression profiles of K
+ and Cl
2 channels. Additionally,
these findings support our earlier hypothesis that HR- and LR-
astrocytes differentially regulate their volume during OGD based
on their different expression levels of ion channels/transporters.
Supporting Information
Figure S1 3D-confocal morphometry of GFAP/EGFP
astrocytes. An EGFP-labeled astrocyte sectioned into a uniformly
spaced (1 mm) set of 2D parallel images [29]. The cell surface was
found in each image using an edge-detecting algorithm, and the
area of the image surrounded by the edge was calculated for each
image (bottom). For the cell soma volume (highlighted by full line)
and the total cell volume (highlighted by dotted line) calculations,
the area of interest was chosen for each individual cell.
(TIF)
Figure S2 Scheme of the experimental sequence for
measuring astrocyte volume changes during OGD.
Superimposed confocal images of an EGFP-labeled cortical
astrocyte in ACSF, during 20-minute OGD and during a 20-
minute co-application of ACSFOGD and inhibitor. The volume
changes were quantified every 10 minutes.
(TIF)
Figure S3 Distribution of two astrocyte populations in
the cortex of GFAP/EGFP mice related to gender or their
location in the cortical layers. A: Percent ratio of HR-
(black)/LR- (white) astrocytes in the cerebral cortex of female
(n=193; left) and male (n=168; right) mice. B: Percent ratio of
HR-(black)/LR- (white) astrocytes in cortical layers I (n=46), II–
III (n=113) and IV–VI (n=133).
(TIF)
Table S1 Sequences of primers used for quantitative
single-cell PCR. Genes used for analyses in experiments I and II
are in bold.
(DOC)
Table S2 Number of cells positive for individual genes –
experiment I.
(DOC)
Table S3 Number of cells positive for individual genes –
experiment II.
(DOC)
Table S4 Experiment I - Spearman correlation coeffi-
cients. Significant correlations are in bold.
(DOC)
Table S5 Experiment II - Spearman correlation coeffi-
cients. Significant correlations are in bold.
(DOC)
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